Waltham, MA. – March 3, 2008: Recognizing that the ePRO data collection needs of Investigator sites and patients are varied and complex, CRF Inc. is pleased to announce that the TrialMax® suite of ePRO software solutions will support Tablet PCs running the Microsoft Windows® Vista™ operating system. Tablet PC-based eDiaries will be easier to use for many patient populations and will enable complex, site-based questionnaires to be administered electronically.  They will provide Investigators the ability to obtain better data, by designing comprehensive patient questionnaires that take advantage of the Tablet’s larger display area and  the stylus or touch screen flexibility for more natural information entry and navigation ease.

“CRF is committed to providing clinical trial Sponsors, Investigators and Subjects with flexible computing options for their different PRO data collection and reporting requirements,” said Pamela McNamara, CEO of CRF, Inc.  “We have seen how the portability and convenience of our PDA and smartphone eDiaries increase compliance and provide Sponsors and Investigators with reliable, contemporaneous, high quality data.  For particular patient populations, the added capabilities that a Tablet PC provides can make a real difference in the compliance rate and therefore the success of the trial.  For example patients with tremors or visual impairment benefit from larger screen objects with which to interact.”

CRF’s full TrialMax® platform capabilities will be utilized for TrialMax® Tablet PCs: the eDiary designer tool, TrialStudio™, will be used to design Tablet PC-based solutions. CRF’s TrialStudio™ tool is well known for its flexibility and ease of use, enabling a collaborative design process with the study team. TrialManager™ , CRF’s web-based trial reporting tool, provides constant real time and controlled access to study data.  These tools are used for all TrialMax® device types (PDAs, smartphones, and Tablet PCs). TrialStudio™ and TrialManager™ support for multiple device platforms allows clinical data collection methods to be easily set up for and to report consistent results across clinical studies using different diaries.

About CRF Inc.
CRF Inc. is the leading global provider of electronic Patient Reported Outcomes (“ePRO”) and wireless data collection solutions for the Life Science Industry. Through innovative technology and a thorough understanding of drug development and mobile computing, the company is driving the change to safer and more efficient, paper-free clinical trials. CRF Inc.'s technology has been used by more than 160,000 patients across 60 countries in 66 languages for 45 indications. The company has demonstrated the industry's highest patient compliance rates - an average 95 percent compliance through Phase I, II, III and IV clinical trials - and unmatched patient and research site acceptance.

CRF Inc.'s award-winning product, TrialMax® Suite, is a flexible and configurable ePRO technology that provides real-time patient monitoring, outstanding data accuracy and increased safety through compliance. Its unique features enable clinical trial sponsors to rapidly collect valuable data and conduct complex clinical trials with greater flexibility than other ePRO solutions. CRF Inc.'s experience, combined with its dedication to ensuring the highest quality and most responsive customer service, has made the company the biopharmaceutical industry's most trusted partner.  For more information, please visit www.crfhealth.com.

TrialMax® is a registered trademark of CRF Inc. All right reserved. TrialCollector™,TrialIntegrator™, TrialLibrary™, TrialManager™, TrialStudio™ and other CRF product references are either a trademark or service mark of CRF Inc. Microsoft Windows and Windows Mobile are registered trademarks of Microsoft Corporation, Microsoft.Net and Vista are trademarks of Microsoft Corporation. Bluetooth is a registered trademark of Motorola Inc. All other trademarks and/or service marks of any other company are the property of their respective owners

###
Media Contacts

Europe:
Rafi Cooper
Buffalo Communications
t. +44 (0) 20 7 292 8685
f. +44 (0) 20 7 287 2905
Rafi.cooper@buffalo.co.uk

US:
Lisa Felice
t. +1 781 835 6539
lisafelice@comcast.net